Western Wealth Management’s Mustang Bio MBIO Stock Holding History

Western Wealth Management’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-60	Closed	-$16.5K	–	663
2023 Q1	$16.5K	Hold	60	–	–	﹤0.01%	635
2022 Q4	$17.8K	Sell	60 -60	-50%	-$20.5K	﹤0.01%	604
2022 Q3	$42K	Buy	+120	New	+$55.6K	﹤0.01%	794

Other funds holding MBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Western Wealth Management's MBIO Position: Q2 2023 in Review

Western Wealth Management sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 60 shares — an estimated $16.5K sold.

Western Wealth Management first reported a position in MBIO in Q3 2022 and held it in 3 quarters. The position peaked at $42K in Q3 2022. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

Western Wealth Management reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
Western Wealth Management sold 60 Mustang Bio shares in Q2 2023, an estimated $16.5K.
Western Wealth Management first reported a position in Mustang Bio in Q3 2022 and held it in 3 quarters.
Western Wealth Management's Mustang Bio position peaked at $42K in Q3 2022.
27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Western Wealth Management's 13F filing for Q2 2023, filed 30 Aug 2023.